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Introduction
!
Gastric adenocarcinoma is the second most lethal
cancer worldwide with only a minority of gastric
adenocarcinomas diagnosed in a curable and re-
sectable form [1,2]. Helicobacter pylori is consid-
ered the most important risk factor for gastric
cancer, by promoting a multi-step process of
chronic gastritis, atrophy, intestinal metaplasia,
dysplasia and, finally, intestinal-type adenocarci-
noma [3]. Secondary prevention through diagno-
sis of premalignant lesions and early gastric can-
cer, and screening or follow-up of individuals at
high risk, would probably be the most immediate
strategies for improving survival [4, 5]. Endoscopy
examination is therefore of paramount impor-
tance. However, endoscopic evaluation of gastric
mucosa correlates poorly with histological find-
ings [6,7], and it is not surprising that ancillary
techniques such as chromoendoscopy have been
used for an accurate diagnosis of precancerous le-
sions and/or invasiveness of cancerous lesions
[8–10]. Even so, for diverse reasons these meth-
ods are not very popular among endoscopists,
particularly those in Western countries.
Diverse descriptions of newmethods of electronic
chromoendoscopy, namely high resolution with
narrow band imaging (NBI), with or without mag-
nification, have been published [11–24]. Good re-
sults have been reported for the imaging of intes-
tinal metaplasia and cancer; however, reliability
A
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Background and study aim: The reliability and ex-
ternal validity of narrow band imaging (NBI) in
the stomach have not been described consistent-
ly. The aim of the current study was to describe
and estimate the accuracy and reliability of a sim-
plified classification system for NBI in the diagno-
sis of gastric lesions.
Methods: Consecutive patients undergoing NBI
endoscopy at two reference centers (n=85, 33%
with dysplasia) were included in two studies. In
total, 224 different areas were biopsied and re-
corded onto video. In the derivation study, pre-
viously described NBI features were analyzed in
order to develop a simplified classification. In the
validation study the accuracy and reliability of
this classification were estimated among three
groups of endoscopists with different levels of ex-
pertise in NBI.
Results: The reliability/accuracy results from the
derivation study allowed the creation of a simpli-
fied NBI classification. In the validation study,
“regular vessels with circular mucosa” (pattern
A) was associated with normal histology (accura-
cy 83%; 95% confidence interval [CI] 75%–90%);
“tubulo-villous mucosa” (pattern B) was associat-
ed with intestinal metaplasia (accuracy 84%; 95CI
77%–91%; positive likelihood ratio [LR+]=4.75);
and “irregular vessels and mucosa” (pattern C)
was associated with dysplasia (accuracy 95%;
95CI 90%–99%; LR+=44.33). The reproducibility
of these patterns was high (k=0.62). “Light-blue
crest” was moderately reliable (k=0.49) but
specific (87%) for intestinal metaplasia. A variable
vascular density (additional pattern+) was the
best feature for Helicobacter pylori gastritis (accu-
racy 70%; 95CI 59%–80%) but showed only fair
reliability (k=0.38). Non-experienced endosco-
pists presented lower agreement (k=0.6 vs. k=
0.75) and accuracy (74% vs. 86%) than interna-
tional experts/experienced endoscopists.
Conclusion: A simplified NBI classification is accu-
rate and reliable for the diagnosis of intestinal
metaplasia and dysplasia. The classification
should be further assessed and validated on a
per-patient assessment of NBI, and by comparing
NBI with other imaging technologies.
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has seldom been evaluated, no study has included the whole
spectrum of lesions, and no external validation of any defined
features has been reported [25].
Thus, the aims of the current study were: to assess the reliability
of previously described NBI features for gastric precancerous and
neoplastic lesions; to simplify the features under a newclassifica-
tion; and to validate this classification on a new sample of pa-
tients and observers, and to assess the accuracy of the classifica-
tion system in endoscopists with a range of NBI experience.
Methods
!
Study design and selection of patients
Patients undergoing routine upper gastrointestinal endoscopy at
two hospitals in the North of Portugal (Portuguese Oncology In-
stitute of Porto and Braga’s Hospital), between September and
December 2009 and between February and April 2010, were con-
secutively considered and included in this study after giving in-
formed consent. Both hospitals are tertiary centers to which pa-
tients with superficial lesions are referred and treated with mini-
mally invasive techniques [26]. Patients with chronic liver dis-
ease, psychiatric conditions, anticoagulant therapy or coagulati-
on disorders, were excluded. The ethical committees of both hos-
pitals approved the study.
Two studies were planned (see●" Fig.e1, available online only):
▶ the first 45 patients (estimated sample of 100 videos), who
were treated between September and December 2009, consti-
tuted the “derivation cohort,” which provided data for a study
on the reliability of previously described mucosal and vascular
features of gastric mucosa using NBI [11–24]. These data were
used to derive a simple NBI classification andwere also subject
to validity testing using histology as the reference test;
▶ in the second study, a “validation cohort” of 40 new patients
(and a new estimated sample of 100 videos), who were asses-
sed between February and April 2010 using endoscopic obser-
vations, provided data for the validation of the new NBI classi-
fication and assessment of the reliability of the classification
within groups of endoscopists with diverse experience.
Endoscopic procedures and selection of videos
Under pharyngeal anesthesia (85% of the patients) or deep seda-
tion (15% of patients) all patients underwent upper gastrointes-
tinal endoscopy using a high resolution (HR) Olympus endoscope
with NBI (EVIS EXERA II video system center GIF-180; Olympus,
Tokyo, Japan). Detailed observation of esophageal, gastric, and
duodenal mucosa was performed and all endoscopic lesions
were described accordingly. High resolution videos of low mag-
nification (×1.5) NBI endoscopy were recorded for further analy-
sis from (subject to patient tolerance) five areas of antral, inci-
sura, and corpus mucosa. Recordings were also made from those
areas with endoscopic changes, either at high resolution white
light endoscopy (HR-WLE) or at HR-NBI. A shift between the HR-
WLE and HR-NBI was used to ensure the position and precision of
the biopsies taken. The total number of histological samples was
equal to the total number of videos recorded. From all of the pro-
cedures, 140 (derivation study) and 119 (validation study) videos
of approximately 10 seconds in duration were recorded consecu-
tively and converted into MPEG-4 files of approximately 10 MB
each using iMovie (Apple Inc., Cupertino, California, USA). No
area was recorded twice. Each video was labeled with a random
number and transferred onto a computerized database. Of the
259 videos recorded only those showing highest quality images
of mucosal morphology and in which the video observation con-
firmed the targeting of the biopsies were selected for use in the
respective studies(124 in the derivation study and 100 in the va-
lidation study). The quality of the videos was assessed by one ex-
perienced endoscopist. The whole potential spectrum of histolo-
gical lesions (no intestinal metaplasia or dysplasia [normal mu-
cosa], presence of intestinal metaplasia, presence of dysplasia
[or carcinoma], and presence ofH. pylori irrespective of histology,
excluding dysplasia) was considered for video selection, both for
the derivation study and for the validation study.
Histopathological procedures
All gastric mucosa specimens were obtained by endoscopic biop-
sy at each area selected for video recording, with the exception of
videos recorded from superficial lesions where a whole muco-
sectomy specimen was obtained. Specimens were fixed in buf-
fered formalin, processed for paraffin embedding, sectioned,
and stained with hematoxylin and eosin. Gastric specimens
were also evaluated for H. pylori infection using modified Giemsa
(2%) stain. Two expert gastrointestinal pathologists, who were
blind to the NBI features, made the final histological diagnosis ac-
cording to the Sydney–Vienna classification [27,28].
Selection of endoscopists
For the derivation study (reliability assessment of previously de-
scribed NBI features), three endoscopists (End1, End2, and End3)
who had previous clinical experience of NBI (>50NBI gastrosco-
pies) each assessed all of the videos; they were blinded to histol-
ogy and to the evaluation of the other endoscopists. Endoscopists
were instructed to evaluate the videos using previously reported
mucosal and vascular features when these features were applic-
able to NBI with low magnification [11–24]. In order to over-
come the problem of an irregular pattern being assigned differ-
ent meanings and being associated with different pathologies
such as H. pylori infection [11], intestinal metaplasia [12], and
dysplasia/cancer [16,18], the endoscopists were instructed to
state the pattern as “irregular” only when they observed a com-
plete architectural loss of the mucosal or vascular pattern (see
below for definition of variables).
In the validation study, nine observers were included:
▶ the three experienced endoscopist observers (End1, End2, and
End3) who participated in the derivation study;
▶ three different gastroenterologists who had not participated
in the first assessment, and who had special interest in chro-
moendoscopy but with diverse NBI experience (<50NBI gas-
troscopies); these were designated non-experienced obser-
vers;
▶ and three international expert NBI endoscopists (from Europe,
USA and Japan); these were designated the expert observers.
All of the observers classified the second set of videos after re-
ceiving a pen drive with a PowerPoint presentation (Microsoft
Office 2003, Microsoft Inc., Redmond, Washington, USA), which
contained the rationale of the derived classification and example
videos.
Variables
In the derivation study the following variables were included
[11–24].
▶ Mucosal pattern: regular circular (well delineated circular/oval
glands), regular tubulo-villous (well delineated tubulo or vil-
lous or ridge glandular pattern) or irregular (glandular pattern
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is clearly irregular with architecture distortion with absent
glandular pattern in some areas possible).
▶ Light blue crest (LBC): presence (yes) or not (no) of blue-whit-
ish slightly raised areas.
▶ White opaque substance (WOS): presence (yes) or not (no) of
white material above the mucosa that could be either well
defined (regular) or not (irregular).
▶ Vascular pattern: regular (vessels well defined in the center or
surrounding the glands) or irregular (areas with clearly
anomalous vessels associated with architecture distortion of
the mucosa). If there were areas where vessels were not seen
clearly but without anomalous configurations they were in-
cluded in the regular group.
▶ Vascular thickness: subjective opinion of normal/thick vessels
or somewhat thin or ultrathin.
▶ Vascular density: high density (almost all of the glands are
surrounded by reddish vessels with some areas with vessel
agglomerates possible) or low density (vessels are not seen
clearly surrounding all of the glands, pale colored vessels).
▶ Variable vascular density (VVD): presence (yes) or not (no) of
alternating areas of high and low density in the same video.
To assess the reliability of these features for inclusion in the clas-
sification, each video was classified by all observers according to
these NBI features and a grade for certainty was assigned. In ad-
dition, each observer was asked tomake an histological diagnosis
based on the NBI features and, again, to assign this diagnosis a
grade of certainty. Histopathological assessment was considered
to be the gold standard or reference test for accuracy estimates.
Statistical analysis
The Statistical Package for Social Sciences (SPSS 17.0 Package Fa-
cility, SPSS Inc., Chicago, Illinois, USA) was used for data support
and analysis.
The proportion of overall agreement was the proportion of cases
for which two observers agreed. The proportions of specific
agreement relative to each category was an estimation of the
probability of, given that one observer makes a rating in a cate-
gory, that the other observers will rate the same. The generalized
formulae, for more than two observers, for the proportions of
overall and specific agreement, were calculated by dividing the
total number of actual agreements by the total number of possi-
ble agreements. Light’s Kappa (mean of the kappa values obtain-
ed from each pair of raters) was also calculated. The nonparamet-
ric bootstrap was used to estimate the 95% confidence intervals
(CIs). Strength of agreement was considered as follows: slight
0–0.2; fair 0.2–0.4; moderate 0.4–0.6; substantial 0.6–0.8; al-
most perfect 0.8–1.
For estimation of sample size, a target estimate standard error of
0.1 in kappa valueswas determined. Each video classificationwas
compared with the histological diagnosis of the corresponding
specimens (gold standard or reference test). Sensitivity, specifici-
ty, and global accuracy were estimated separately and for all nine
observers combined, along with the 95%CIs. Likelihood ratios
(LR) were estimated based on mean sensitivity and specificity es-
timates.
Results
!
Derivation study
Description of participants and videos
Patient characteristics and a description of endoscopic proce-
dures included in the study are shown in●" Table1. In 20% of
the patients five or more biopsies were possible and in 28% four
biopsies of different areas were performed. Due to the specialist
nature of the institutions, a large number of endoscopic examina-
tions were performed for dysplasia or mucosectomy (36%). This
yielded a significant number of histological samples of dysplasia
(n=23) and metaplasia (n=40). A total of 124 good quality videos
(67 normal mucosa, 34 intestinal metaplasia, and 23 dysplasia
Table 1 Description of
participants and endoscopic
procedures (n = 85).
Patients Total
n=85
Derivation
n=45
Validation
n=40
Male sex, n (%) 50 (59) 28 (62) 22 (55)
Age, mean (range), years 61 (21–91) 61 (21–91) 61 (49–80)
Number of biopsies, median (range) 3 (1–6) 3 (1–5) 3 (1–6)
Indications for upper gastrointestinal endoscopy, n
Follow-up/previous diagnosis of dysplasia 23 11 12
Dyspepsia 16 12 4
Follow-up after precursors conditions (metaplasia) 16 6 10
Follow-up after gastric mucosectomy 14 8 6
For gastric mucosectomy 11 5 6
Other (e. g. GERD) 5 3 2
Main endoscopic findings, n
Gastric superficial lesions 21 11 10
Normal 17 13 4
Papular-erythematous gastritis 15 8 7
Gastric scar 13 6 7
Gastric irregularity 11 5 6
Erosive gastritis 8 2 6
Histological diagnosis per patient, n
Normal mucosa (antrum and body) 21 12 9
Intestinal metaplasia antrum 22 11 11
Intestinal metaplasia corpus 14 8 6
Dysplasia (one or more areas) 28 14 14
H. pylori infection 38 21 17
GERD, gastroesophageal reflux disease.
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[20 high grade, 3 low grade]), 50 of which H. pylori positive, were
recorded to accompany 140 histological samples.
Accuracy and reproducibility of previously described NBI
features
The correlation of different NBI features with histology, the relia-
bility measures for all described NBI features, and the presump-
tive histological results are shown in●" Table2 and●" Table3.
The identification of different mucosal and vascular patterns was
associatedwith high reproducibility (Pa>80% with k=0.71 and k
=0.89, respectively). The identification of LBC or WOS was also
associated with substantial reproducibility (Pa>80% with k=
0.58 and k=0.57, respectively). Conversely, other vascular fea-
tures such as thickness or density had only weak to moderate re-
producibility (Pa=0.62 and Pa=0.65 with k=0.19 and k=0.24,
respectively).
Variable vascular density was the most accurate parameter for
identification ofH. pylori gastritis, although inter-observer agree-
ment was only fair (Pa=0.61 and k=0.21).
Mucosal and vascular patterns derived from the histology results
were highly valid for metaplasia and dysplasia (●" Table3). The
histological diagnosis proposed by the observers showed a high
agreement with histological diagnosis (Pa=0.82, k=0.71) but
only a weak to moderate agreement for H. pylori infection (Pa=
0.61, k=0.21).
Development of a simplified classification
Using the results from the derivation study, a simplified classifi-
cation of gastric lesions was established (●" Table4 and●" Fig.2).
The presence of LBC contributed but was not essential to the di-
agnosis of intestinal metaplasia. Also, WOS contributed to the di-
agnosis of dysplasia or cancer; however, it could only be consid-
ered when an irregular mucosal/vascular pattern was seen.
Validation study
Description of participants and videos
The characteristics of patients and endoscopic procedures inclu-
ded in the validation study are shown in●" Table1, andwere sim-
ilar to those of the derivation study. Dysplasia in previous biop-
sies and mucosectomy were important indications for endoscopy
(45%). A total of 100 good quality videos (40 normal mucosa, 38
intestinal metaplasia, 22 dysplasia [19 high grade, 3 low grade],
and 39 of which had H. pylori) were recorded to accompany 119
histological samples.
Accuracy and reproducibility of the new NBI classification
●" Table5 shows the correlation between NBI patterns and histo-
logical findings, inter-observer agreement, and accuracy for the
different NBI patterns proposed. WOSwas not evaluated because
only one cancer lesion presented this feature in the validation
study. The identification of the different patterns was associated
with substantial reproducibility (Pa=0.76, k=0.62). There were
no differences in the reproducibility between the experts and
the experienced observers. However, the agreement between
the group of experienced observers was higher when compared
with the non-experienced group (k=0.75 vs. 0.60). The identifi-
cation of the LBC was associated with a moderate agreement (Pa
=0.77, k=0.49); again, however, this agreement was better be-
tween the experienced than between the non-experienced ob-
servers (k=0.77 vs. k=0.40, respectively). The reproducibility of
the variable vascular density NBI pattern for H. pylori was fair to
moderate (Pa=0.71, k=0.38) with no differences between the
groups.
The newNBI patterns derived and proposedwere highly accurate
for metaplasia and, in particular, for dysplasia (●" Table5). The ac-
curacy of the patterns (A–C) was higher in the experts and ex-
perienced observers compared with the non-experienced (pat-
tern A: accuracy 87% vs. 74%; pattern B: 88% vs. 76%; pattern C:
97% vs. 91%) as well as the accuracy of LBC (87% vs. 81%). There
Table 3 Derivation study: features on narrow band imaging with accuracy estimates for the diagnosis of the several gastric lesions.
Mucosal/vascular pat-
tern
Outcome Mean sensitivity (range)
[95%CI]
Mean specificity (range)
[95%CI]
Mean accuracy (range)
[95%CI]
Regular, tubulo-villous Intestinal metaplasia 0.89 (0.85–0.94)
[0.78–1.00]
0.90 (0.88–0.95)
[0.84–0.96]
0.90 (0.87–0.94)
[0.85–0.95]
Irregular Dysplasia 0.96 (0.92–1.00)
[0.82–1.00]
0.98 (0.96–0.99)
[0.92–1.00]
0.97 (0.97–0.98)
[0.95–1.00]
Light blue crest Intestinal metaplasia 0.48 (0.42–0.55)
[0.31–0.66]
0.96 (0.95–0.97)
[0.89–0.99]
0.83 (0.81–0.85)
[0.77–0.90]
Variable vascular
density
H. pylori infection 0.62 (0.45–0.69)
[0.46–0.75]
0.70 (0.58–0.78)
[0.56–0.82]
0.66 (0.52–0.73)
[0.56–0.75]
Table 4 Proposed classification for gastric lesions on narrow band imaging. Regular mucosal and vascular patterns favor the absence of dysplasia, ridge or
tubulo-villous being found in areas with intestinal metaplasia. The light blue crest should be considered specific for intestinal metaplasia but its absence does
not exclude intestinal metaplasia. A variable vascular density may favor the presence of H. pylori infection.
Pattern designation A B Hp+ C
Mucosal pattern Regular
circular
Regular
ridge/tubulo-villous
Light blue crest Regular Irregular/absent
White opaque
substance
Vascular pattern Regular
Thin/peripheric (body
(b) or thick/central (a)
vessels
Regular Regular
with variable vascular
density
Irregular
Expected outcome Normal Intestinal metaplasia H. pylori infection Dysplasia
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were no differences between the groups with regard to H. pylori
pattern accuracy.
The predictive values for the classification were as follows (●" Ta-
ble6). For the diagnosis of intestinal metaplasia using pattern B, a
likelihood ratio for a positive test (presence of a certain mucosal
pattern) was estimated to be 4.75 and the likelihood ratio of its
absence (LR– ) was 0.13.The diagnosis of intestinal metaplasia
using LBC showed LR+=5.13 and LR–=0.37.Variable vascular
density produced predictive values of LR+=2.53 and LR–=0.48.
Importantly, pattern C presented LR+=44.33 and LR–=0.16 for
dysplasia.
Discussion
!
To the best of our knowledge this is the first study of reproduci-
bility and validity of HR-NBI endoscopy for the identification of
several different gastric lesions that incorporates the entire spec-
trum of precancerous and intestinal-type cancer lesions. The
study provides significant evidence that NBI endoscopy may be
a reproducible and accurate method for the diagnosis of gastric
pre-neoplastic and cancer lesions. Indeed, some NBI features
were very reproducible and were associated consistently with
gastric lesions. Furthermore, it appears that a learning curve for
the identification of these NBI features should be allowed for, as
expertise is associated with a more precise identification of the
lesions and a more accurate diagnosis.
Fig.2 The simplified classification of gastric lesions using narrow band
imaging. a Pattern Aa – regular circular/oval mucosa surrounding regular
thick vessels in the center of the gland; histology showed normal antrum
mucosa; b Pattern Aa+–variable vascular density with areas of low (right)
and high (top and center) density but with a pattern of a normal antrum;
histology showed H. pylori gastritis. These areas of low or high density may
render the visualization of narrow band imaging (NBI) features difficult,
however, they should not be confused with the irregularity seen in dyspla-
sia (f); c Pattern Ab – regular circular mucosa that is surrounded by regular
vessels, not in the center of the gland as in the antrum; histology showed
normal body mucosa. It is important to recognize that normal body and
antrum mucosa have a slightly different NBI appearance; d Pattern B –
regular ridge/tubulo-villous mucosa with regular vessels; histology showed
intestinal metaplasia; e Pattern B+with light blue crest – ridge mucosa with
some blue-whitish slightly raised areas and a variable vascular density;
histology showed intestinal metaplasia with H. pylori gastritis; f Pattern C –
irregular mucosa with irregular vessels and a complete architectural loss of
the mucosal and vascular pattern; this flat lesion presented high grade
dysplasia.
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The main limitations to the study were the fact that NBI features
were not compared with HR-WLE and that some gastric lesions
that can present dysplasia, such as erosions or ulcers, were not
included. Also not included were some gastric pathologies that
are associated with increased cancer risk, such as autoimmune
gastropathy (pernicious anemia) or Ménétrier disease. Therefore,
the results should be regarded as applicable to patients with pre-
cancerous conditions and intestinal Lauren-type gastric adeno-
carcinoma. In addition, as low grade dysplasia was observed in
only six lesions it cannot be accurately stated that the classifica-
tion will be applicable equally to low grade dysplasia and high
grade dysplasia/intramucosal adenocarcinoma. Also, diffuse-
type adenocarcinomas were not included in the current study.
Other studies have provided interesting results on the role of NBI
for the detection of gastric pre-neoplastic and cancer lesions
[11–24]. However, there are several aspects of the previous stud-
ies that must be borne in mind. The definitions of the NBI fea-
tures were different between the studies, only one study evaluat-
ed the reproducibility of some NBI features, and no single study
included the whole spectrum of gastric lesions in the same clas-
sification or evaluation [25]. Moreover, almost all of the data
come from Japan, and therefore applicability to Western coun-
tries is uncertain. Another consideration is that almost all of the
previous studies used NBI with high magnification (up to ×80),
which is not practical in clinical routine as these endoscopes are
not available in most centers, at least not in Western countries.
To our knowledge, only three other studies have attempted to
identify H. pylori gastritis. Alaboudy et al. [23] was the only study
that used NBI without magnification; however, the NBI patterns
in this study were complex and no reproducibility analysis of
these complex patterns was undertaken. Bansal et al. [11] asso-
ciated irregularity of mucosal and vascular patterns and a low
vascular density to H. pylori gastritis. However, they did not de-
fine irregularity, nor was any reproducibility analysis undertak-
en, and a low number of patients was included. Tahara et al. [19]
associated H. pylori gastritis to different patterns with enlarged
pits and increased density of irregular vessels. However, again,
no reproducibility analysis was done and in neither of these stud-
ies was dysplasia considered. This is important because, in our
opinion, the “irregularity” described by those studies is clearly
different from the irregularity that is present in cancer lesions.
To overcome this problem in the current study, irregularity and
the different patterns described in previous studies was defined
as “variable vascular density,” which did indeed show a positive
association with H. pylori gastritis; however, the reproducibility
of this feature on NBI was relatively low and independent of ex-
pertise. The results from all of the studies suggest that, even
though NBI may be superior to WLE for the identification of H.
pylori gastritis, NBI (at least without magnification) does not re-
place other diagnostic tests (e.g. histology) that are clearly more
sensitive, specific, and reproducible.
In the case of intestinal metaplasia identification, however, the
existing evidence suggests that NBI may be an important tool. In-
deed, the two studies by Bansal and Tahara associated a tubulo-
villous mucosal pattern to intestinal metaplasia with great accu-
racy [11, 19]. These results were confirmed in the present study,
with 92% accuracy of this mucosal pattern for the diagnosis of
metaplasia by experienced observers. Uedo et al. [21] suggested
that the finding of LBC with NBI is also very accurate for intestinal
metaplasia; reproducibility of this finding was not evaluated in
the study. In the current study, however, LBC was not very sensi-
tive for metaplasia (68% global sensitivity), though it was specific
(87% global specificity). Nevertheless, at least when using a low
magnification and the Olympus EXERA system (Uedo used high
magnification and the LUCERA system), it appears that a tubulo-
villous mucosal pattern is more consistently associated and in a
more reproducible manner with metaplasia.
Evaluation of dysplasia/cancer using NBI has been performed in
several studies. Initial studies have also attempted to establish
NBI patterns that could help to predict the degree of tumor differ-
entiation [13,18,20]. Despite some positive results, the authors
concluded that NBI was not able to replace histology for tumor
differentiation [18]. In these studies, however, the authors did
not evaluate which NBI features could help to differentiate be-
tween benign and dysplastic lesions. Some authors suggest that
“adenoma” may have an NBI pattern resembling pattern B in the
current study [20,22], but the precise histological diagnosis of
the lesions was not provided in previous studies and it is likely
that they presented foci of low grade dysplasia in the context of
extensive intestinal metaplasia. In contrast, Kaise et al. [16] eval-
uated NBI criteria for cancer diagnosis in gastric depressed le-
sions. They concluded that irregular vascular and mucosal pat-
terns were very specific for cancer, although sensitivity was low
and reproducibility only moderate. These relatively modest re-
sults may be because cancer lesions were compared only with a
particular benign lesion –gastric erosions. Indeed, the same
group of authors using the same criteria for dysplasia but evalu-
ating different suspicious lesions found that the sensitivity and
specificity of magnification endoscopy NBI for the diagnosis of
dysplasiawere >90% [29]. Ezoe et al. [14] obtained similar results
using similar NBI criteria. In the current study, the accuracy of ir-
regular mucosal and vascular patterns, considered as a complete
architecture distortion, was evaluated for the diagnosis of gastric
dysplasia in the context of all benign lesions and using only low
magnification. The results were very impressive, showing not
only that these NBI criteria are very accurate for the diagnosis of
Table 6 Estimates of predictive values.
Feature Outcome Prevalence (pretest probability) Positive predictive value, % LR– Negative predictive value, %
LR+ 1% 10% 20% 50% 1% 10% 20% 50%
Intestinal metaplasia
B pattern 4.75 5 34 54 83 0.13 0.10 1 3 11
Light blue
crest 5.13 5 36 56 84 0.37 0.40 4 8 27
Dysplasia
C pattern 44.33 31 83 92 98 0.16 0.20 2 4 14
LR, likelihood ratio
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dysplasia, similar to the study of Kato et al. [29], but also that they
allow dysplasia diagnosis in a very reproducible manner. Taking
all of the evidence together, it can be suggested that this pattern
irregularity with NBI appears to be a good method for the diag-
nosis of gastric dysplasia, at least for high grade dysplasia.
What is the clinical utility of all these aspects? The current study
is not a comparative study of NBI with WLE, it is not possible to
state whether or not NBI is better than WLE for the diagnosis of
gastric lesions. However, comparing the current results with
those from other studies that used HR-WLE [30–32] NBI appears
to be clearly superior to WLE for the diagnosis of these types of
gastric lesions. More importantly, Kaise et al. [16], Ezoe et al.
[14], and Kato et al. [29] compared WLE with NBI for the diagno-
sis of cancer and concluded that the accuracy of NBI is significant-
ly superior to WLE. Recently, Cappelle et al. [12] compared the
yield of NBI toWLE in the surveillance of patients with a previous
history of intestinal metaplasia or dysplasia. They used the same
NBI system as in the current study and similar definitions; how-
ever, H. pylori gastritis was not considered and no reproducibility
analysis was done. Capelle et al. showed that NBI was better than
routine WLE for the diagnosis of intestinal metaplasia and dys-
plasia. Taking all of these data together, we can say that NBI may
help to select suspicious areas for biopsy and probably replace
the random biopsy method with a biopsy strategy directed to
the suspicious areas of metaplasia and/or dysplasia. Moreover,
NBI can also help to delineate gastric lesions for endoscopic gas-
tric resection. Indeed, Kadowaki et al. [15], using similar NBI
criteria for dysplasia, have shown that NBI is better than WLE for
early cancer demarcation recognition.
Another aspect that is relevant to the current study is the fact
that endoscopists withmore NBI experience and expertise recog-
nize NBI patterns with more agreement and with more diagnos-
tic accuracy. This is important as it reflects a learning curve for
this new technology and suggests that even highly experienced
endoscopists should undergo training before using NBI in clinical
routine. Moreover, data are presented as range of expected val-
ues for accuracy. These results may therefore help endoscopists
to judge the accuracy of their diagnosis when NBI is used for the
assessment of gastric lesions in clinical practice.
Using likelihood ratios, it was possible to estimate the predictive
values of this classification in different scenarios (●" Table 6). For
reference centers in countries with a high prevalence of precan-
cerous and cancerous lesions, as in Portugal and Eastern Europe-
an countries, this classification will able to confirm/predict the
presence of dysplasia (post-test probability or positive predictive
values of 83%–98%) and to exclude both intestinal metaplasia
and dysplasia within centers of low prevalence countries (nega-
tive predictive value lower than 1%). Further studies of a per-pa-
tient assessment of utility in such specific settings, namely by
comparing NBI with WLE or other technologies are needed.
In conclusion, HR-NBI endoscopy is an efficacious technique for
the characterization of gastric intestinal metaplasia and, in
particular, dysplasia. Irregularity of vascular/mucosal pattern is
identified in a reproducible manner and it is consistently asso-
ciated with gastric dysplasia. HR-NBI endoscopy may be an im-
portant tool for the early diagnosis of gastric pre-neoplastic and
neoplastic lesions and for therapeutic procedures.
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Inception cohort (n=45)
of consecutive patients in two tertiary hospitals submitted to upper GI endoscopy with HR-NBI Olympus 
Vídeos and histological assessment (n=140)
Selection of quality videos (n= 124)*
*estimated number of 100 for Pa and kappa confidence intervals estimates with clinical relevance
Derivation of a simplified classification 
Interobserver agreement study 
for previously published described 
NBI features (observers End 1, 2 and 3)
Accuracy (histology as reference test) 
for previously published described NBI features 
and presumptive endoscopic diagnosis 
Validating cohort (n=40)
of new sample of consecutive patients in two tertiary hospitals 
submitted to upper GI endoscopy with HR-NBI Olympus
Vídeos and histological assessment (n=119)
Selection of quality videos (n= 100)*
 Interobserver agreement study 
 for the simplified NBI classification 
 3 groups of observers according to expertise
 ▪Observers End 1, 2 and 3 (experienced)
 ▪Observers Nonexperience
 ▪Observers Experts
Accuracy (histology as reference test) 
for the simplified NBI classification 
and presumptive endoscopic diagnosis 
 
Fig.e1 Two studies were planned: 1) a consecu-
tive sample of 45 patients (yielding an estimated
sample of 100 videos), observed across two tertiary
hospitals between September and December 2009,
constituted the “derivation cohort,” which provided
data for a reliability study of previously described
mucosal and vascular features using high resolution
narrow band imaging (HR-NBI) in gastric mucosa
[11–24]. These features were used to develop a
simplified NBI classification, which also considered
validity measures (using histology as the reference
test); 2) a “validation cohort” of 40 new patients
(and a new estimated sample of 100 videos) was
assessed between February and April 2010; endo-
scopic observations were used to validate the new
NBI classification and assess the reliability of the
classification within groups of endoscopists with di-
verse experience.
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